Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention

Background: Up to 30% of patients with atrial fibrillation (AF) have coronary artery disease, and many undergo percutaneous coronary intervention (PCI). In the setting of acute coronary syndrome with PCI, or high-risk elective PCI, Canadian AF guidelines recommend 1-30 days of acetylsalicylic acid,...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Caylie M. Poirier, PharmD, ACPR, Aleesa A. Carter, BSP, PharmD, ACPR, Yvonne Kwan, BScPhm, ACPR, Jessica Koo, BScPhm, ACPR, Jill M. Westlund, BScPhm, ACPR, Fadi Alkass, PharmD, Kori Leblanc, BScPhm, ACPR, PharmD
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2023-11-01
Sarja:CJC Open
Linkit:http://www.sciencedirect.com/science/article/pii/S2589790X23002196

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X23002196

Samankaltaisia teoksia